Name	Ozenoxacin
Description	Ozenoxacin (T-3912) is a quinolone antibacterial. It shows potent activities against the main microorganisms isolated from soft tissue and skin infections.
In vitro	Ozenoxacin shows potent antibacterial activities against clinical isolates of Gram-positive microorganisms (MICs: 0.008 to 4 mg/L). Ozenoxacin shows good activities against strains of MRSA, MSSA, MSSE, and MRSE with 2, 3, or 4 mutations in the gyrA and grlA (parC) genes [1]. Ozenoxacin inhibits MSSA strains and S. agalactiae strains, with the rates of resistance of >10?10 and 5.3?×?10?10, respectively. The maximum MIC value for mutant strains is 8 mg/L for Ozenoxacin [2].
Storage	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice.
Solubility Information	DMSO : 1 mg/mL, Sonication is recommended.
Keywords	Inhibitor \| T3912 \| T 3912 \| Bacterial \| inhibit \| Ozenoxacin
Inhibitors Related	Neomycin sulfate \| Sulfamethoxazole sodium \| Dimethyl sulfoxide
Related Compound Libraries	FDA-Approved & Pharmacopeia Drug Library \| Bioactive Compound Library \| Drug Repurposing Compound Library \| Anti-Bacterial Compound Library \| FDA-Approved Drug Library \| Bioactive Compounds Library Max

Ozenoxacin NEW

Product Introduction